The company was established in Europe in Sweden. The leading representative office of defined VC is situated in the Stockholm.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Denmark. Among the most popular fund investment industries, there are Pharmaceutical, Hospital. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Light Sciences Oncology, AdvanDx, OxThera.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. The top activity for fund was in 2005. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this SLS Venture performs on 8 percentage points less the average number of lead investments.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the SLS Venture, startups are often financed by LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. In the next rounds fund is usually obtained by LD Pensions, Industrifonden, Sunstone Life Science Ventures.
Related Funds
Funds with similar focus
Fund Name | Location |
Daocin Capital | China, Hangzhou, Zhejiang |
Estalea | California, Santa Barbara, United States |
First Green Partners | Minneapolis, Minnesota, United States |
Innovation Department | New York, New York, United States |
Latin American Media Group | Brazil, São Paulo, Sao Paulo |
SEIS | England, London, United Kingdom |
Sheridan Legacy Group | Chicago, Illinois, United States |
Solomon Global Holdings | Columbus, Ohio, United States |
The Fishman Group | Israel, Tel Aviv, Tel Aviv District |
Tourbillon Global Ventures | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
AdvanDx | $8M | 12 Oct 2009 | Woburn, Massachusetts, United States | ||
AdvanDx | $15M | 18 Sep 2007 | Woburn, Massachusetts, United States | ||
AdvanDx | $5M | 08 May 2006 | Woburn, Massachusetts, United States | ||
Light Sciences Oncology | $32M | 14 Dec 2005 | Bellevue, Washington, United States | ||
BioPheresis | $8M | 13 May 2005 | Baden-Württemberg | ||
Symphogen | $25M | 05 Nov 2004 | Capital Region of Denmark | ||
AdvanDx | $5M | 24 Nov 2003 | Woburn, Massachusetts, United States | ||
Nuevolution | $15M | 10 Oct 2003 | Copenhagen, Capital Region of Denmark, Denmark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
AdvanDx | $8M | 12 Oct 2009 | Woburn, Massachusetts, United States | ||
AdvanDx | $15M | 18 Sep 2007 | Woburn, Massachusetts, United States | ||
AdvanDx | $5M | 08 May 2006 | Woburn, Massachusetts, United States | ||
Light Sciences Oncology | $32M | 14 Dec 2005 | Bellevue, Washington, United States | ||
BioPheresis | $8M | 13 May 2005 | Baden-Württemberg | ||
Symphogen | $25M | 05 Nov 2004 | Capital Region of Denmark | ||
AdvanDx | $5M | 24 Nov 2003 | Woburn, Massachusetts, United States | ||
Nuevolution | $15M | 10 Oct 2003 | Copenhagen, Capital Region of Denmark, Denmark |